Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EDAP NASDAQ:POCI NASDAQ:STIM NASDAQ:TMCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDAPEdap Tms$3.61+4.6%$3.74$1.21▼$5.05$135.27M-0.155,970 shs7,107 shsPOCIPrecision Optics$4.67+1.4%$4.29$3.55▼$6.04$36.06M0.2326,693 shs10,351 shsSTIMNeuronetics$2.01-7.6%$1.45$0.80▼$4.85$139.51M1.132.14 million shs835,944 shsTMCITreace Medical Concepts$1.89+0.3%$1.62$1.17▼$7.78$122.12M1.1783,122 shs36,832 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDAPEdap Tms-0.58%+5.18%+1.77%-15.23%+60.84%POCIPrecision Optics+7.98%+10.05%+7.73%-18.58%+9.65%STIMNeuronetics+7.43%+32.32%+42.76%+40.00%-51.78%TMCITreace Medical Concepts+1.08%-1.57%+29.66%-11.32%-74.32%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDAPEdap Tms$3.61+4.6%$3.74$1.21▼$5.05$135.27M-0.155,970 shs7,107 shsPOCIPrecision Optics$4.67+1.4%$4.29$3.55▼$6.04$36.06M0.2326,693 shs10,351 shsSTIMNeuronetics$2.01-7.6%$1.45$0.80▼$4.85$139.51M1.132.14 million shs835,944 shsTMCITreace Medical Concepts$1.89+0.3%$1.62$1.17▼$7.78$122.12M1.1783,122 shs36,832 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDAPEdap Tms-0.58%+5.18%+1.77%-15.23%+60.84%POCIPrecision Optics+7.98%+10.05%+7.73%-18.58%+9.65%STIMNeuronetics+7.43%+32.32%+42.76%+40.00%-51.78%TMCITreace Medical Concepts+1.08%-1.57%+29.66%-11.32%-74.32%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDAPEdap Tms 2.00Hold$6.0066.25% UpsidePOCIPrecision Optics 1.00SellN/AN/ASTIMNeuronetics 2.00Hold$3.0049.63% UpsideTMCITreace Medical Concepts 1.86Reduce$4.77153.05% UpsideCurrent Analyst Ratings BreakdownLatest POCI, STIM, EDAP, and TMCI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/20/2026TMCITreace Medical Concepts Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/9/2026EDAPEdap Tms HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$14.00 ➝ $10.003/19/2026STIMNeuronetics Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$7.00 ➝ $3.003/2/2026TMCITreace Medical Concepts Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$7.50 ➝ $7.00(Data available from 5/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDAPEdap Tms$70.53M1.92N/AN/A$0.52 per share6.94POCIPrecision Optics$19.09M1.89N/AN/A$1.60 per share2.92STIMNeuronetics$149.16M0.94N/AN/A$0.38 per share5.28TMCITreace Medical Concepts$212.69M0.57N/AN/A$1.37 per share1.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDAPEdap Tms-$29.25M-$0.77N/AN/AN/A-41.24%-100.07%-37.38%5/7/2026 (Estimated)POCIPrecision Optics-$5.78M-$0.92N/AN/AN/A-28.33%-60.56%-32.67%5/14/2026 (Estimated)STIMNeuronetics-$39M-$0.59N/AN/AN/A-26.15%-121.26%-27.67%N/ATMCITreace Medical Concepts-$59M-$0.94N/AN/AN/A-27.74%-59.91%-28.44%5/8/2026 (Estimated)Latest POCI, STIM, EDAP, and TMCI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2026Q1 2026TMCITreace Medical Concepts-$0.31N/AN/AN/A$45.96 millionN/A5/7/2026Q1 2026EDAPEdap Tms-$0.22N/AN/AN/A$19.31 millionN/A5/5/2026Q1 2026STIMNeuronetics-$0.17-$0.16+$0.01-$0.16$34.17 million$34.45 million3/25/2026Q4 2025EDAPEdap Tms-$0.16-$0.25-$0.09-$0.26$21.28 million$22.22 million3/17/2026Q4 2025STIMNeuronetics-$0.12-$0.10+$0.02-$0.10$40.84 million$41.78 million2/27/2026Q4 2025TMCITreace Medical Concepts-$0.15-$0.15N/A-$0.15$61.76 million$62.52 million2/17/2026Q2 2026POCIPrecision OpticsN/A-$0.23N/A-$0.23N/A$7.37 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthEDAPEdap TmsN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/ASTIMNeuroneticsN/AN/AN/AN/AN/ATMCITreace Medical ConceptsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEDAPEdap Tms0.841.541.19POCIPrecision Optics0.111.050.62STIMNeuronetics2.512.021.87TMCITreace Medical Concepts0.644.313.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDAPEdap Tms62.74%POCIPrecision Optics13.71%STIMNeuronetics53.59%TMCITreace Medical Concepts84.08%Insider OwnershipCompanyInsider OwnershipEDAPEdap Tms0.23%POCIPrecision Optics14.40%STIMNeuronetics8.40%TMCITreace Medical Concepts23.42%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEDAPEdap Tms23037.48 million37.40 millionOptionablePOCIPrecision Optics807.73 million6.62 millionNot OptionableSTIMNeuronetics18069.58 million63.74 millionOptionableTMCITreace Medical Concepts25064.78 million49.61 millionOptionablePOCI, STIM, EDAP, and TMCI HeadlinesRecent News About These CompaniesLucid Diagnostics (NASDAQ:LUCD) & Treace Medical Concepts (NASDAQ:TMCI) Financial SurveyMay 4 at 3:46 AM | americanbankingnews.comHow The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst ExpectationsMay 3 at 6:18 PM | finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from AnalystsMay 3 at 4:19 AM | marketbeat.comTreace Medical Concepts (TMCI) to Release Quarterly Earnings on FridayMay 1, 2026 | americanbankingnews.comTreace Medical Concepts (TMCI) to Release Earnings on FridayMay 1, 2026 | marketbeat.comWeber Capital Management LLC ADV Invests $1.45 Million in Treace Medical Concepts, Inc. $TMCIApril 27, 2026 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Upgraded to Sell at Wall Street ZenApril 27, 2026 | marketbeat.comTreace Medical Concepts, Inc. to Release First Quarter 2026 Financial Results and Host Conference CallApril 24, 2026 | quiverquant.comQTreace to Report First Quarter 2026 Financial Results on May 8, 2026April 24, 2026 | globenewswire.comWall Street Zen Downgrades Treace Medical Concepts (NASDAQ:TMCI) to Strong SellApril 19, 2026 | marketbeat.comHow The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product PlansApril 18, 2026 | finance.yahoo.comTreace Medical Concepts Announces Leadership Transition and OutlookApril 11, 2026 | theglobeandmail.comWall Street Zen Upgrades Treace Medical Concepts (NASDAQ:TMCI) to SellApril 11, 2026 | marketbeat.comTreace Medical Concepts (TMCI) price target increased by 12.28% to 4.08April 10, 2026 | msn.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Reduce" from AnalystsApril 8, 2026 | marketbeat.comTreace Medical Concepts, Inc.: Treace Announces First Surgical Cases with the SuperBite Compression Screw SystemApril 7, 2026 | finanznachrichten.deTreace Announces First Surgical Cases with the SuperBite™ Compression Screw SystemApril 7, 2026 | globenewswire.comTreace Medical Concepts (TMCI) price target decreased by 10.94% to 3.63March 28, 2026 | msn.comHow The Story Is Shifting For Treace Medical Concepts (TMCI) After Analyst Target ResetsMarch 20, 2026 | uk.finance.yahoo.comTreace Medical Earnings Call Balances Progress and PressureMarch 2, 2026 | tipranks.comTreace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...February 27, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThese 3 Defense Giants Beat Q1 Estimates—So Why Did Their Stocks Still Fall?By Jessica Mitacek | April 22, 2026Alphabet’s Earnings Didn’t Just Beat—They Changed the StoryBy Ryan Hasson | April 30, 2026Corning Beats Q1 Estimates but Drops 9% on Guidance MissBy Ryan Hasson | April 29, 2026Homebuilder Earnings: D.R. Horton Sticks Out as Pulte & NVR Sales TankBy Leo Miller | April 27, 2026Alcoa Rebounds as Aluminum Tightens, But a Q1 Miss Tests the RallyBy Jessica Mitacek | April 22, 2026POCI, STIM, EDAP, and TMCI Company DescriptionsEdap Tms NASDAQ:EDAP$3.61 +0.16 (+4.61%) As of 10:52 AM Eastern This is a fair market value price provided by Massive. Learn more.EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.Precision Optics NASDAQ:POCI$4.66 +0.07 (+1.41%) As of 11:20 AM Eastern This is a fair market value price provided by Massive. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.Neuronetics NASDAQ:STIM$2.00 -0.17 (-7.60%) As of 11:21 AM Eastern This is a fair market value price provided by Massive. Learn more.Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.Treace Medical Concepts NASDAQ:TMCI$1.88 +0.01 (+0.27%) As of 11:21 AM Eastern This is a fair market value price provided by Massive. Learn more.Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Just How Big a Problem Could Amazon’s Cash Burn Rate Be? BlackBerry Rewrites Its Own Operating System Grab Holdings Faces Hurdles, But Upside Potential Is Hard to Ignore Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
